To access this element change to forms mode OFF
Grant Award View - GA59379
Overcoming resistance to venetoclax
GA ID:
GA59379
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Aug-2019
Publish Date:
17-Oct-2019
Category:
Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2024
Value (AUD):
$489,362.65
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 19/20 1.1 Health and Medical Research
Grant Program:
Investigator
Grant Activity:
Overcoming resistance to venetoclax
Purpose:
Venetoclax is a novel non-chemotherapy-based agent for treating blood cancers that has been associated with excellent responses even among patients with relapsed or refractory disease. Unfortunately, the use of this drug is limited by the development of resistance. We aim to understand why resistance occurs to venetoclax and to undertake systematic laboratory and clinical studies to identify rational approaches we can take to overcome this resistance in order to improve outcomes for patients.
GO ID:
GO Title:
Investigator Grants 2019
Internal Reference ID:
GNT1177718
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA